Role of serum and glucocorticoid-regulated kinase-1 in the protective effects of erythropoietin during renal ischemia/reperfusion injury

K. Rusai, Ágnes Prókai, B. Szebeni, Andrea Fekete, András Treszl, A. Vannay, V. Müller, G. Reusz, Uwe Heemann, Jens Lutz, T. Tulassay, Attila J. Szabó

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Erythropoietin (EPO) protects the kidneys from ischemia/reperfusion (I/R) injury; however, the exact signalling mechanisms are not fully understood. The serum and glucocorticoid-regulated kinase 1 (SGK1) is an anti-apoptotic protein kinase regulated through the phosphatidylinositol 3-kinase (PI3-kinase) pathway by cellular stimuli, hormones and growth factors. The objective of the present study was to examine the role of SGK1 in the renoprotective effects of EPO in renal I/R injury.In vitro, cultures of HEK293 cells were exposed to 16 h hypoxia. Incubation with EPO at a doses of 400 U/ml exerted a protective effect on cell death assessed by LDH release and Annexin V FACS analysis. This was paralleled by up-regulation of SGK1 expression, as well as phosphorylation. Downregulation of SGK1 expression by small interfering RNA technique ameliorated the anti-apoptotic effect of EPO treatment.In an in vivo rat model of unilateral renal I/R injury, rats were treated with 500 U/kg EPO 24 h prior to ischemia. EPO resulted in less severe tissue injury and ameliorated the elevation in creatinine and urea nitrogen levels 24 h after reperfusion. Furthermore, SGK1 expression and phosphorylation were higher in EPO compared to vehicle-treated rats as demonstrated by real-time PCR, Western blot and immunofluorescence technique.We conclude that EPO protects from renal I/R injury and SGK1 might contribute to the mediation of EPO effects under ischemic conditions.

Original languageEnglish
Pages (from-to)1173-1181
Number of pages9
JournalBiochemical Pharmacology
Volume79
Issue number8
DOIs
Publication statusPublished - Apr 2010

Fingerprint

Erythropoietin
Reperfusion Injury
Kidney
Rats
Phosphorylation
Phosphatidylinositol 3-Kinase
serum-glucocorticoid regulated kinase
Apoptosis Regulatory Proteins
HEK293 Cells
Annexin A5
Hormones
Cell death
Protein Kinases
Small Interfering RNA
Reperfusion
Fluorescent Antibody Technique
Urea
Real-Time Polymerase Chain Reaction
Creatinine
Intercellular Signaling Peptides and Proteins

Keywords

  • Apoptosis
  • EPO
  • Hypoxia
  • Ischemia/reperfusion
  • Kidney
  • SGK1

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry

Cite this

Role of serum and glucocorticoid-regulated kinase-1 in the protective effects of erythropoietin during renal ischemia/reperfusion injury. / Rusai, K.; Prókai, Ágnes; Szebeni, B.; Fekete, Andrea; Treszl, András; Vannay, A.; Müller, V.; Reusz, G.; Heemann, Uwe; Lutz, Jens; Tulassay, T.; Szabó, Attila J.

In: Biochemical Pharmacology, Vol. 79, No. 8, 04.2010, p. 1173-1181.

Research output: Contribution to journalArticle

@article{06b2724b4fee488ab9f8cfa40c7b8655,
title = "Role of serum and glucocorticoid-regulated kinase-1 in the protective effects of erythropoietin during renal ischemia/reperfusion injury",
abstract = "Erythropoietin (EPO) protects the kidneys from ischemia/reperfusion (I/R) injury; however, the exact signalling mechanisms are not fully understood. The serum and glucocorticoid-regulated kinase 1 (SGK1) is an anti-apoptotic protein kinase regulated through the phosphatidylinositol 3-kinase (PI3-kinase) pathway by cellular stimuli, hormones and growth factors. The objective of the present study was to examine the role of SGK1 in the renoprotective effects of EPO in renal I/R injury.In vitro, cultures of HEK293 cells were exposed to 16 h hypoxia. Incubation with EPO at a doses of 400 U/ml exerted a protective effect on cell death assessed by LDH release and Annexin V FACS analysis. This was paralleled by up-regulation of SGK1 expression, as well as phosphorylation. Downregulation of SGK1 expression by small interfering RNA technique ameliorated the anti-apoptotic effect of EPO treatment.In an in vivo rat model of unilateral renal I/R injury, rats were treated with 500 U/kg EPO 24 h prior to ischemia. EPO resulted in less severe tissue injury and ameliorated the elevation in creatinine and urea nitrogen levels 24 h after reperfusion. Furthermore, SGK1 expression and phosphorylation were higher in EPO compared to vehicle-treated rats as demonstrated by real-time PCR, Western blot and immunofluorescence technique.We conclude that EPO protects from renal I/R injury and SGK1 might contribute to the mediation of EPO effects under ischemic conditions.",
keywords = "Apoptosis, EPO, Hypoxia, Ischemia/reperfusion, Kidney, SGK1",
author = "K. Rusai and {\'A}gnes Pr{\'o}kai and B. Szebeni and Andrea Fekete and Andr{\'a}s Treszl and A. Vannay and V. M{\"u}ller and G. Reusz and Uwe Heemann and Jens Lutz and T. Tulassay and Szab{\'o}, {Attila J.}",
year = "2010",
month = "4",
doi = "10.1016/j.bcp.2009.11.022",
language = "English",
volume = "79",
pages = "1173--1181",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Role of serum and glucocorticoid-regulated kinase-1 in the protective effects of erythropoietin during renal ischemia/reperfusion injury

AU - Rusai, K.

AU - Prókai, Ágnes

AU - Szebeni, B.

AU - Fekete, Andrea

AU - Treszl, András

AU - Vannay, A.

AU - Müller, V.

AU - Reusz, G.

AU - Heemann, Uwe

AU - Lutz, Jens

AU - Tulassay, T.

AU - Szabó, Attila J.

PY - 2010/4

Y1 - 2010/4

N2 - Erythropoietin (EPO) protects the kidneys from ischemia/reperfusion (I/R) injury; however, the exact signalling mechanisms are not fully understood. The serum and glucocorticoid-regulated kinase 1 (SGK1) is an anti-apoptotic protein kinase regulated through the phosphatidylinositol 3-kinase (PI3-kinase) pathway by cellular stimuli, hormones and growth factors. The objective of the present study was to examine the role of SGK1 in the renoprotective effects of EPO in renal I/R injury.In vitro, cultures of HEK293 cells were exposed to 16 h hypoxia. Incubation with EPO at a doses of 400 U/ml exerted a protective effect on cell death assessed by LDH release and Annexin V FACS analysis. This was paralleled by up-regulation of SGK1 expression, as well as phosphorylation. Downregulation of SGK1 expression by small interfering RNA technique ameliorated the anti-apoptotic effect of EPO treatment.In an in vivo rat model of unilateral renal I/R injury, rats were treated with 500 U/kg EPO 24 h prior to ischemia. EPO resulted in less severe tissue injury and ameliorated the elevation in creatinine and urea nitrogen levels 24 h after reperfusion. Furthermore, SGK1 expression and phosphorylation were higher in EPO compared to vehicle-treated rats as demonstrated by real-time PCR, Western blot and immunofluorescence technique.We conclude that EPO protects from renal I/R injury and SGK1 might contribute to the mediation of EPO effects under ischemic conditions.

AB - Erythropoietin (EPO) protects the kidneys from ischemia/reperfusion (I/R) injury; however, the exact signalling mechanisms are not fully understood. The serum and glucocorticoid-regulated kinase 1 (SGK1) is an anti-apoptotic protein kinase regulated through the phosphatidylinositol 3-kinase (PI3-kinase) pathway by cellular stimuli, hormones and growth factors. The objective of the present study was to examine the role of SGK1 in the renoprotective effects of EPO in renal I/R injury.In vitro, cultures of HEK293 cells were exposed to 16 h hypoxia. Incubation with EPO at a doses of 400 U/ml exerted a protective effect on cell death assessed by LDH release and Annexin V FACS analysis. This was paralleled by up-regulation of SGK1 expression, as well as phosphorylation. Downregulation of SGK1 expression by small interfering RNA technique ameliorated the anti-apoptotic effect of EPO treatment.In an in vivo rat model of unilateral renal I/R injury, rats were treated with 500 U/kg EPO 24 h prior to ischemia. EPO resulted in less severe tissue injury and ameliorated the elevation in creatinine and urea nitrogen levels 24 h after reperfusion. Furthermore, SGK1 expression and phosphorylation were higher in EPO compared to vehicle-treated rats as demonstrated by real-time PCR, Western blot and immunofluorescence technique.We conclude that EPO protects from renal I/R injury and SGK1 might contribute to the mediation of EPO effects under ischemic conditions.

KW - Apoptosis

KW - EPO

KW - Hypoxia

KW - Ischemia/reperfusion

KW - Kidney

KW - SGK1

UR - http://www.scopus.com/inward/record.url?scp=77249133525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77249133525&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2009.11.022

DO - 10.1016/j.bcp.2009.11.022

M3 - Article

C2 - 19961832

AN - SCOPUS:77249133525

VL - 79

SP - 1173

EP - 1181

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 8

ER -